Lin v. Solta Medical, Inc.

District Court, N.D. California·Decided July 15, 2022·No. 4:21-cv-05062·Unknown

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA

7 HSIN LIN, Case No. 21-cv-05062-PJH 8 Plaintiff,

9 v. CASE MANAGEMENT AND PRETRIAL ORDER 10 SOLTA MEDICAL, INC.,

11 Defendant. 12 13 Good cause appearing, the court hereby adopts the case management statement 14 of the parties except as modified by the following:

15 PRETRIAL SCHEDULE

16 TRIAL DATE: March 11, 2024, at 8:30 a.m., Courtroom 3, 3rd Fl., 1301 Clay Street, Oakland, California. 17 JURY [X] COURT [] 18 TRIAL LENGTH: No more than 10 days. 19 PRETRIAL CONFERENCE DATE: February 15, 2024, at 2:00 P.M. 20 DISPOSITIVE MOTIONS (Only one summary judgment motion per party is permitted 21 without leave of court) TO BE HEARD BY: November 2, 2023. 22 NON-EXPERT DISCOVERY CUTOFF: August 1, 2023 23 DISCLOSURE OF EXPERTS (retained and non-retained): PLA: April 1, 2023. 24 DISCLOSURE OF EXPERTS (retained and non-retained): DEF: June 1, 2023. 25 EXPERT DISCOVERY CUTOFF: July 1, 2023. 26 DISCOVERY LIMITATIONS: 27 Interrogatories: Requests for Documents: 1 DISCOVERY DISPUTES: Parties must file a joint letter brief not to exceed five pages. 2 On receipt of the Joint Letter, the court will determine what, if any, future proceedings are necessary 3 LAST DAY TO AMEND PLEADINGS: no later than 90 days before fact discovery cutoff 4 date a motion or a stipulation must be filed so sufficient time remains to conduct 5 discovery on added claims or parties. Doe defendants must be identified by this deadline, or they will be dismissed. 6

7 [X] REFERRED TO ADR FOR Private Mediation to be completed by August 1, 2023. 8 ADDITIONAL ORDERS: 9 PRETRIAL INSTRUCTIONS 10 A. PRETRIAL MOTIONS 11 1. All dispositive motions are heard no later than 120 days before trial, unless 12 leave of court is obtained for another deadline. 13 2. Only one summary judgment motion may be filed by each side, absent leave of 14 court. Leave of court may be sought if multiple parties comprise one or both sides. 15 Leave of court may be obtained by filing a motion for administrative relief pursuant 16 to Civ. L. R. 7-11, or by requesting a case management conference or informal 17 telephone conference. 18 3. Separate statements of undisputed facts in support of or in opposition to motions 19 for summary judgment shall NOT be filed. See Civil L. R. 56-2. The parties may 20 file a truly joint statement of undisputed facts only if all parties agree that the facts 21 are undisputed. 22 4. Objections to evidence may no longer be filed separately but must be contained 23 within a brief or memorandum. Civil L. R. 7-3. 24 5. Each party filing or opposing a motion shall also serve and file a proposed order 25 which sets forth the relief or action sought and a short statement of the rationale of 26 decision, including citation of authority that the party requests the court to adopt. 27 1 6. Chambers copies of each electronically-filed document must include on each 2 page the running header created by the ECF system and must be delivered to the 3 Clerk's Office by noon the day following its filing. (Note: These deadlines differ 4 from those in Civil L. R. 5-1(e)(7)(A).) All documents must be stapled or bound by 5 a two-pronged fastener, and all exhibits to declarations or requests for judicial 6 notice must be tabbed. 7 7. Footnotes in briefs appearing in smaller than the 12-point font required for the 8 text, will be stricken, see Civil L. R. 3-4(c)(2), as will footnotes that are so 9 numerous as to be clearly designed to defeat the page limits found at Civil L. R. 7- 10 2 - 7-4. Any brief must separate sentences by 2 spaces after each sentence. 11 8. Motions pursuant to Daubert v. Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 12 (1993), challenging the reliability of expert testimony, may be noticed for hearing 13 on the date dispositive motions will be heard or on any available hearing date up 14 to and including the date of the final pretrial conference. Irrespective of the 15 hearing date, the briefs shall be filed in accordance with Civil L. R. 7-2 - 7-5, that 16 is, on a 35-day briefing schedule. 17 9. Motions in limine are limited to motions to exclude specific items of evidence on 18 a ground and upon such authority as would be sufficient to sustain an objection to 19 such evidence at trial. The court will not generally consider a motion presenting a 20 purely legal issue in the guise of a motion in limine. 21 10. Discovery motions will be referred to a Magistrate Judge for resolution. The words 22 "Discovery Matter" shall appear in the caption of all documents relating to 23 discovery to insure proper routing. 24 11. Confidential and/or sealed documents shall be handled in accordance with this 25 court's standing order and Civil L.R. 79-5, both of which the parties shall consult 26 before moving for a protective order or requesting a sealing order. Requests to 27 seal documents used in conjunction with dispositive motions are rarely granted 1 B. FINAL PRETRIAL CONFERENCE 2 1. Each party shall attend personally or by counsel who will try the case. 3 2. Not less than 35 days prior to the pretrial conference, all counsel and/or parties 4 shall meet and confer regarding preparation of the joint pretrial statement. 5 3. Not less than 28 days prior to the pretrial conference, counsel and/or parties 6 shall: 7 a. Serve and file a joint pretrial statement. (Separately filed statements will not be 8 accepted by the court and monetary sanctions will be imposed upon the party 9 failing to cooperate in the preparation of a joint statement). 10 The pretrial statement shall include the following: 11 i. A brief description of the substance of the claims and defenses which 12 remain to be decided. 13 ii. A detailed statement of all relief sought, itemizing all elements of 14 damages claimed. 15 iii. A statement of all relevant undisputed facts to which the parties will 16 stipulate for incorporation into the trial record without the necessity of 17 supporting testimony or exhibits. 18 iv. A statement of all relevant disputed facts which remain to be decided. 19 v. A statement of stipulations requested or proposed. 20 vi. A brief statement of disputed points of law concerning liability and relief. 21 Legal argument on these points shall be reserved for the trial briefs. 22 vii. A statement of whether bifurcation or a separate trial of specific issues is 23 feasible and desired. 24 viii. A statement summarizing the status of settlement negotiations and 25 indicating whether further negotiations are likely to be productive. 26 b. Serve and file trial briefs (not to exceed 25 pages), which shall specify each 27 cause of action and defense remaining to be tried along with a statement of the 1 c. Serve and file no more than ten motions in limine, which shall be filed in one 2 document not to exceed 25 pages; 3 d. Serve and file a list of deposition excerpts for witnesses who will not testify in 4 person, (specifying the witness, page and line references) and other discovery 5 responses that will be offered at trial; 6 e. Serve and file a list of all witnesses to be called at trial, in person or by 7 deposition, other than solely for impeachment or rebuttal, with a brief statement 8 describing the substance of the testimony to be given; 9 f. Serve and file a numerical list of exhibits that will be offered as evidence in a 10 party's case in chief in support of a claim or defense, with a brief statement 11 describing the substance and purpose of each exhibit and the name of the 12 sponsoring witness; 13 g. Exchange exhibits which shall be premarked with an exhibit sticker (example 14 attached), tabbed and in binders. Plaintiff shall use numbers (1, 2, 3, etc.) and 15 defendant shall use numbers preceded by a letter (A-1, A-2, A-3, etc.).

Free access — add to your briefcase to read the full text and ask questions with AI

Lin v. Solta Medical, Inc., (N.D. Cal. 2022).

Lin v. Solta Medical, Inc. (Lin v. Solta Medical, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)